Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News STEADYMED Ltd STDY

Healthcare Drug Manufacturers - Specialty & Generic
"SteadyMed Ltd is a specialty pharmaceutical company. It has operations in Israel and United States which include research and development, marketing and business development."

Recent & Breaking News (NDAQ:STDY)

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of SteadyMed Ltd. -- STDY

Business Wire November 2, 2017

Glancy Prongay & Murray LLP Continues Investigation on Behalf of SteadyMed Ltd. Investors (STDY)

Business Wire November 1, 2017

SteadyMed Receives Notice of Allowance for its European Patent Relating to Enhanced Reduction of Infusion-Site Pain

GlobeNewswire October 12, 2017

SteadyMed Submits Type A Meeting Request Package to FDA

GlobeNewswire September 28, 2017

INVESTOR ALERT: Goldberg Law PC Announces an Investigation of SteadyMed Ltd.

Business Wire September 8, 2017

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of SteadyMed Ltd. (STDY) Investors

Business Wire September 6, 2017

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of SteadyMed Ltd.

Business Wire September 1, 2017

Glancy Prongay & Murray LLP Commences Investigation on Behalf of SteadyMed Ltd. Investors (STDY)

Business Wire September 1, 2017

Investor Alert: Kaplan Fox Announces Investigation Of SteadyMed Ltd.

PR Newswire September 1, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of SteadyMed Ltd.

Business Wire August 31, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of SteadyMed Ltd. (STDY)

PR Newswire August 31, 2017

Mid-Afternoon Market Update: Shoe Carnival Climbs On Upbeat Earnings; Genesco Shares Drop

Benzinga.com  August 31, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of SteadyMed Ltd. - STDY

PR Newswire August 31, 2017

Mid-Day Market Update: Crude Oil Up 2.5%; DryShips Shares Decline On News Of SEC Subpoena

Benzinga.com  August 31, 2017

SteadyMed Receives Refusal to File Letter from FDA for Trevyent® New Drug Application

GlobeNewswire August 31, 2017

SteadyMed Reports Second Quarter 2017 Financial Results and Provides Corporate Update

GlobeNewswire August 11, 2017

SteadyMed to Present at the 2017 Wedbush PacGrow Healthcare Conference

GlobeNewswire August 9, 2017

SteadyMed Appoints Jeff Myers M.D. Ph.D. Vice President of Medical Affairs

GlobeNewswire July 31, 2017

SteadyMed Submits New Drug Application for Trevyent®

GlobeNewswire June 30, 2017

SteadyMed to Present at the 2017 JMP Securities Life Sciences Conference

GlobeNewswire June 13, 2017